[CNBC Television] The market seems disconnected from bad economic news: Grant Thornton economist

🎯 Загружено автоматически через бота: 🚫 Оригинал видео: 📺 Данное видео принадлежит каналу «CNBC Television» (@CNBCtelevision). Оно представлено в нашем сообществе исключительно в информационных, научных, образовательных или культурных целях. Наше сообщество не утверждает никаких прав на данное видео. Пожалуйста, поддержите автора, посетив его оригинальный канал. ✉️ Если у вас есть претензии к авторским правам на данное видео, пожалуйста, свяжитесь с нами по почте support@, и мы немедленно удалим его. 📃 Оригинальное описание: Diane Swonk of Grant Thornton and Andrew Slimmon of Morgan Stanley Asset Management join “Squawk on the Street“ to discuss the markets after weak economic data. Stocks surged after a report said a Gilead Sciences drug showed some effectiveness in treating the coronavirus, giving investors some hope there could be a treatment solution that helps the country reopen faster from the widespread shutdowns that have plunged the economy into a recession. The Dow Jones Industrial Average was up 400 points, or 1.7%, after trading up by as much as 600 points earlier in the session. Losses in Apple and Amazon capped the broader market’s gains. Amazon has been a beneficiary of people staying at home because of the pandemic and would lose that benefit if an effective treatment allowed the U.S. economy to open up sooner The S&P 500 traded 1.6% higher, while the Nasdaq Composite advanced %. (Click here for the latest market news.) The gain put the S&P 500 on track for its first back-to-back weekly gains since early February. The S&P 500 has risen 1.7%, while the Nasdaq Composite has climbed 5.2%, lifted by double-digit gains in Amazon and Netflix. The 30-stock Dow was up about 0.5% this week. A jump in Boeing shares and a roll-out Thursday evening of the White House plan to reopen the economy also added to the bullish tone on Friday. Gilead shares jumped more than 7% after STAT news reported that a Chicago hospital treating coronavirus patients with remdesivir in a trial were recovering rapidly from severe symptoms. The publication cited a video it obtained where the trial results were discussed. For access to live and exclusive video from CNBC subscribe to CNBC PRO: » Subscribe to CNBC TV: » Subscribe to CNBC: » Subscribe to CNBC Classic: Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide. Connect with CNBC News Online Get the latest news: Follow CNBC on LinkedIn: Follow CNBC News on Facebook: Follow CNBC News on Twitter: Follow CNBC News on Instagram: #CNBC #CNBC TV